PDF-funded scientist-clinician Oren Levy, M.D., Ph.D., wants to slow Parkinson's and he has already found some clues.Learn More
Your Donations Make a Difference
Your support makes the research of Dr. Hess and Dr. Earhart possible, allowing us to learn about the role of genetics and the potential of exercise in Parkinson's.
Watch Our Video & Learn More
PDF Champions: Pancakes for Parkinson's
Monday, November 30 (Lynchburg, VA)
Join Pranamya Mahankali and members of the Liberty University College of Osteopathic Medicine Student Osteopathic Medical Association (LUCOM-SOMA) for the second annual Pancakes for Parkinson's to benefit PDF. The "breakfast for dinner" event will also feature a presentation on Parkinson's and free PDF educational resources for the community.
Rapamycin Prevents Mitochondrial Dysfunction and PD Symptoms in Mouse Model
November 13, 2015
Research published September 16 in the Journal of Neuroscience finds that the drug rapamycin, an immunosuppressant drug already approved by the FDA for transplant patients, can protect brain cells and mitochondria, and ease movement symptoms in a mouse model of Parkinson’s disease (PD). Several years back, previous studies by a team at the PDF Research Center at Columbia University Medical Center, paved the way for this research by establishing the importance of rapamycin as a molecule of interest in PD therapies.